294 related articles for article (PubMed ID: 21435183)
1. coral Software: QSAR for Anticancer Agents.
Benfenati E; Toropov AA; Toropova AP; Manganaro A; Gonella Diaza R
Chem Biol Drug Des; 2011 Jun; 77(6):471-6. PubMed ID: 21435183
[TBL] [Abstract][Full Text] [Related]
2. QSAR models for toxicity of organic substances to Daphnia magna built up by using the CORAL freeware.
Toropova AP; Toropov AA; Benfenati E; Gini G
Chem Biol Drug Des; 2012 Mar; 79(3):332-8. PubMed ID: 22136580
[TBL] [Abstract][Full Text] [Related]
3. CORAL: QSPR model of water solubility based on local and global SMILES attributes.
Toropov AA; Toropova AP; Benfenati E; Gini G; Leszczynska D; Leszczynski J
Chemosphere; 2013 Jan; 90(2):877-80. PubMed ID: 22921649
[TBL] [Abstract][Full Text] [Related]
4. QSAR as a random event: modeling of nanoparticles uptake in PaCa2 cancer cells.
Toropov AA; Toropova AP; Puzyn T; Benfenati E; Gini G; Leszczynska D; Leszczynski J
Chemosphere; 2013 Jun; 92(1):31-7. PubMed ID: 23566368
[TBL] [Abstract][Full Text] [Related]
5. SMILES-based QSAR approaches for carcinogenicity and anticancer activity: comparison of correlation weights for identical SMILES attributes.
Toropov AA; Toropova AP; Benfenati E; Gini G; Leszczynska D; Leszczynski J
Anticancer Agents Med Chem; 2011 Dec; 11(10):974-82. PubMed ID: 22023046
[TBL] [Abstract][Full Text] [Related]
6. CORAL: quantitative structure-activity relationship models for estimating toxicity of organic compounds in rats.
Toropova AP; Toropov AA; Benfenati E; Gini G; Leszczynska D; Leszczynski J
J Comput Chem; 2011 Sep; 32(12):2727-33. PubMed ID: 21656789
[TBL] [Abstract][Full Text] [Related]
7. SMILES-based QSAR models for the calcium channel-antagonistic effect of 1,4-dihydropyridines.
Veselinović AM; Milosavljević JB; Toropov AA; Nikolić GM
Arch Pharm (Weinheim); 2013 Feb; 346(2):134-9. PubMed ID: 23280520
[TBL] [Abstract][Full Text] [Related]
8. SMILES-based QSAR model for arylpiperazines as high-affinity 5-HT(1A) receptor ligands using CORAL.
Veselinović AM; Milosavljević JB; Toropov AA; Nikolić GM
Eur J Pharm Sci; 2013 Feb; 48(3):532-41. PubMed ID: 23287365
[TBL] [Abstract][Full Text] [Related]
9. QSAR analysis of 1,4-dihydro-4-oxo-1-(2-thiazolyl)-1,8-naphthyridines with anticancer activity.
Atanasova M; Ilieva S; Galabov B
Eur J Med Chem; 2007 Sep; 42(9):1184-92. PubMed ID: 17408810
[TBL] [Abstract][Full Text] [Related]
10. QSPR modeling bioconcentration factor (BCF) by balance of correlations.
Toropov AA; Toropova AP; Benfenati E
Eur J Med Chem; 2009 Jun; 44(6):2544-51. PubMed ID: 19232785
[TBL] [Abstract][Full Text] [Related]
11. Prediction of retention characteristics of heterocyclic compounds.
Nesměrák K; Toropov AA; Toropova AP; Yildiz I; Yalcin I; Brozikova M; Klimešová V; Waisser K
Anal Bioanal Chem; 2015 Dec; 407(30):9185-9. PubMed ID: 26427498
[TBL] [Abstract][Full Text] [Related]
12. QSPR modelling of dielectric constants of π-conjugated organic compounds by means of the CORAL software.
Achary PG
SAR QSAR Environ Res; 2014; 25(6):507-26. PubMed ID: 24716837
[TBL] [Abstract][Full Text] [Related]
13. CORAL: building up the model for bioconcentration factor and defining it's applicability domain.
Toropov AA; Toropova AP; Lombardo A; Roncaglioni A; Benfenati E; Gini G
Eur J Med Chem; 2011 Apr; 46(4):1400-3. PubMed ID: 21295893
[TBL] [Abstract][Full Text] [Related]
14. SMILES-based optimal descriptors: QSAR modeling of carcinogenicity by balance of correlations with ideal slopes.
Toropov AA; Toropova AP; Benfenati E
Eur J Med Chem; 2010 Sep; 45(9):3581-7. PubMed ID: 20570021
[TBL] [Abstract][Full Text] [Related]
15. CORAL Software: Analysis of Impacts of Pharmaceutical Agents Upon Metabolism via the Optimal Descriptors.
Toropova MA; Raska I; Toporova AP; Raskova M
Curr Drug Metab; 2017; 18(6):500-510. PubMed ID: 28260514
[TBL] [Abstract][Full Text] [Related]
16. SMILES-based optimal descriptors: QSAR analysis of fullerene-based HIV-1 PR inhibitors by means of balance of correlations.
Toropov AA; Toropova AP; Benfenati E; Leszczynska D; Leszczynski J
J Comput Chem; 2010 Jan; 31(2):381-92. PubMed ID: 19479738
[TBL] [Abstract][Full Text] [Related]
17. SMILES-based quantitative structure-property relationships for half-wave potential of N-benzylsalicylthioamides.
Nesmerak K; Toropov AA; Toropova AP; Kohoutova P; Waisser K
Eur J Med Chem; 2013 Sep; 67():111-4. PubMed ID: 23850571
[TBL] [Abstract][Full Text] [Related]
18. CORAL: QSAR models for acute toxicity in fathead minnow (Pimephales promelas).
Toropova AP; Toropov AA; Lombardo A; Roncaglioni A; Benfenati E; Gini G
J Comput Chem; 2012 May; 33(12):1218-23. PubMed ID: 22371019
[TBL] [Abstract][Full Text] [Related]
19. Monte Carlo QSAR models for predicting organophosphate inhibition of acetycholinesterase.
Veselinović JB; Nikolić GM; Trutić NV; Živković JV; Veselinović AM
SAR QSAR Environ Res; 2015 Jun; 26(6):449-60. PubMed ID: 26043064
[TBL] [Abstract][Full Text] [Related]
20. Quasi-SMILES: quantitative structure-activity relationships to predict anticancer activity.
Toropova AP; Toropov AA
Mol Divers; 2019 May; 23(2):403-412. PubMed ID: 30306392
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
